← Open Payments lookup

MELISSA KIMBERLIN: Open Payments

NPI 1801293915 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$261 in 15 payments from 8 companies in 2025. Trend: 2023 $33 · 2024 $404 · 2025 $261

Food & beverage: $261
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$55
Lundbeck LLC3$47
Alkermes, Inc.2$39
Teva Pharmaceuticals USA, Inc.2$37
Axsome Therapeutics, Inc.2$29
IDORSIA PHARMACEUTICALS US INC1$23
Braeburn Inc.1$17
Vanda Pharmaceuticals Inc.1$14

Products named: CAPLYTA, REXULTI, UZEDY, Auvelity, Quviviq, ARISTADA, LYBALVI, BRIXADI.

Industry payments across IN — which companies pay providers there.